University of Pennsylvania Health System at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of Pennsylvania Health System brings 2 presentations to AMP 2026 in Seattle. Its sessions focus on running next-generation sequencing panels in a clinical laboratory. Topics include rapid myeloid sequencing on the MiSeq i100 and making residual disease testing for blood cancers sensitive without slowing the workflow.
| Organization | AMP 2026 Attendance |
|---|---|
University of Pennsylvania Health System Philadelphia, PA | |
Academic health system in Philadelphia, the clinical arm of Penn Medicine, with molecular pathology and genomic diagnostic laboratories. | Workshop Wed, Nov 11 10:00am–10:50am Rapid NGS That Scales: Clinical Implementation of oncoReveal® Myeloid NGS on the MiSeq i100 Bringing a myeloid sequencing panel in house on a benchtop sequencer, reaching roughly three-day turnaround across 200 samples. Workshop Wed, Nov 11 11:00am–11:50am Deep Sensitivity Meets Workflow Efficiency: Optimizing HemOnc MRD Testing in Your Laboratory Quantitative PCR for myeloid residual disease, including laboratory experience validating a new PML-RARA kit and its workflow. |
Instantly find 20 buyers from University of Pennsylvania Health System
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction